Gilead Sciences said Wednesday it will invest $11 billion in U.S. research and manufacturing in the coming years, joining ...

The new investments, unveiled on Wednesday, will supplement an already planned spending of $21 billion to boost U.S.

Shares of Gilead Sciences Inc. GILD rose 1.04% to $98.90 Wednesday, on what proved to be an all-around great trading session ...

As the Trump administration slashes funding for HIV-related research and infrastructure, Gilead, Immunocore and more are ...

Gilead Sciences announced $11 billion in new planned investment in the U.S. to boost its domestic manufacturing and research ...

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we ...

The new plans are in addition to $21B that the drug manufacturer has already committed to U.S. research, development and ...

Eight years after 'The Handmaid's Tale' debuted, the long-awaited final season is unfolding in turbulent times.

Businesses that are solid enough to perform well over extended periods, while consistently raising their payouts, are ...

The company added to a recent flurry of pledges by pharmaceutical companies, promising $11 billion in new capital and ...

Gilead Sciences adds $11B to its U.S. investment plan, boosting manufacturing, R&D, and job creation. Read more here.

Interim results from the ongoing Phase III ASSURE trial demonstrated that Livdelzi maintained a consistent biochemical ...